SCHEMBL5175696

SCHEMBL5175696

CN(C(=O)Oc1ccc(OCCN2CCC(O)(c3ccccc3)CC2)cc1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ LMNA P02545 2/20 0.53
▸ LTA4H P09960 3/20 0.51
▸ RAB9A P51151 3/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ DRD2 P14416 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.44
▸ ACHE P22303 1/20 0.44
▸ ESR1 P03372 1/20 0.44
▸ ESR2 Q92731 1/20 0.44
▸ HTR1A P08908 1/20 0.43
▸ DRD1 P21728 1/20 0.43
▸ DRD5 P21918 1/20 0.43
▸ SLC6A2 P23975 1/20 0.43
▸ HTR2A P28223 1/20 0.43
▸ SLC6A4 P31645 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5175157 0.90 MEN1 (0.56) ALDH1A1MEN1KMT2ALMNALTA4H
SCHEMBL5647648 0.81 LTA4H (0.64) LTA4HESR1ESR2HRH3
SCHEMBL5175324 0.79 KCNA5 (0.54) ALDH1A1MEN1KMT2ALMNALTA4H
SCHEMBL4688810 0.78 MEN1 (0.62) ALDH1A1MEN1KMT2ALMNALTA4H
SCHEMBL5174031 0.78 MEN1 (0.57) ALDH1A1MEN1KMT2ALMNALTA4H
Hydrochloric Acid SCHEMBL7406712 0.77 MEN1 (0.61) ALDH1A1MEN1KMT2ALMNALTA4H
SCHEMBL5175644 0.77 MEN1 (0.58) ALDH1A1MEN1KMT2ALMNALTA4H
SCHEMBL5175984 0.76 LTA4H (0.55) MEN1KMT2ALTA4HKDM4EHTR1A
SCHEMBL5176107 0.76 HTR1A (0.54) LTA4HDRD2HTR1AHTR7
SCHEMBL5175935 0.76 ALDH1A1 (0.51) ALDH1A1MEN1KMT2ALMNALTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1868605-A2 PHENYL AND PYRIDYL LTA4H MODULATORS Janssen Pharmaceutica, N.V. (BE) 2007-12-26 — — EP claimed
WO-2006105304-A2 PHENYL AND PYRIDYL LTA4H MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — WO claimed
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — US claimed
EP-1868605-A2 PHENYL AND PYRIDYL LTA4H MODULATORS Janssen Pharmaceutica, N.V. (BE) 2007-12-26 — — EP disclosed
WO-2006105304-A2 PHENYL AND PYRIDYL LTA4H MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — WO disclosed
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators LTA4H, LTB4R, LTC4S ALDH1A1 1142/4885MEN1 4858/4885KMT2A 3196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback